The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 20,258 | 772,600 | SH | DFND | 1,2 | 772,600 | 0 | 0 | |
ALIMERA SCIENCES INC | COM | 016259103 | 7,759 | 1,683,162 | SH | DFND | 1,2 | 1,683,162 | 0 | 0 | |
ANTARES PHARMA INC | COM | 036642106 | 5,824 | 2,800,000 | SH | DFND | 1,2 | 2,800,000 | 0 | 0 | |
ARADIGM CORP | COM NO PAR VALUE | 038505400 | 7,402 | 1,002,962 | SH | DFND | 1,2 | 1,002,962 | 0 | 0 | |
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 5,502 | 311,222 | SH | DFND | 1,2 | 311,222 | 0 | 0 | |
ATHERSYS INC | COM | 04744L106 | 121 | 100,000 | SH | Put | DFND | 1,2 | 100,000 | 0 | 0 |
ATHERSYS INC | COM | 04744L106 | 977 | 807,700 | SH | Call | DFND | 1,2 | 807,700 | 0 | 0 |
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 5,812 | 1,941,144 | SH | DFND | 1,2 | 1,941,144 | 0 | 0 | |
BIODELIVERY SCIENCES INTL IN | COM | 09060J106 | 82 | 10,300 | SH | DFND | 1,2 | 10,300 | 0 | 0 | |
BIODEL INC | COM NEW | 09064M204 | 4,132 | 4,011,511 | SH | DFND | 1,2 | 4,011,511 | 0 | 0 | |
BOVIE MEDICAL CORP | COM | 10211F100 | 7,477 | 2,680,000 | SH | DFND | 1,2 | 2,680,000 | 0 | 0 | |
CALADRIUS BIOSCIENCES INC | COM | 128058104 | 4,630 | 2,476,120 | SH | DFND | 1,2 | 2,476,120 | 0 | 0 | |
DERMA SCIENCES INC | COM PAR $.01 | 249827502 | 2,005 | 280,000 | SH | DFND | 1,2 | 280,000 | 0 | 0 | |
DYAX CORP | COM | 26746E103 | 12,528 | 472,739 | SH | DFND | 1,2 | 472,739 | 0 | 0 | |
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 1,575 | 35,000 | SH | DFND | 1,2 | 35,000 | 0 | 0 | |
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 687 | 8,400 | SH | DFND | 1,2 | 8,400 | 0 | 0 | |
EXELIXIS INC | COM | 30161Q104 | 2,801 | 745,000 | SH | Put | DFND | 1,2 | 745,000 | 0 | 0 |
FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 16,856 | 678,595 | SH | DFND | 1,2 | 678,595 | 0 | 0 | |
OCERA THERAPEUTICS INC | COM | 67552A108 | 7,463 | 1,963,777 | SH | DFND | 1,2 | 1,963,777 | 0 | 0 | |
OREXIGEN THERAPEUTICS INC | COM | 686164104 | 2,178 | 440,000 | SH | DFND | 1,2 | 440,000 | 0 | 0 | |
PARATEK PHARMACEUTICALS INC | COM | 699374302 | 10,703 | 415,338 | SH | DFND | 1,2 | 415,338 | 0 | 0 | |
RELYPSA INC | COM | 759531106 | 7,942 | 240,000 | SH | DFND | 1,2 | 240,000 | 0 | 0 | |
SAGENT PHARMACEUTICALS INC | COM | 786692103 | 3,450 | 141,900 | SH | DFND | 1,2 | 141,900 | 0 | 0 | |
STEMLINE THERAPEUTICS INC | COM | 85858C107 | 5,593 | 475,200 | SH | DFND | 1,2 | 475,200 | 0 | 0 | |
STREAMLINE HEALTH SOLUTIONS | COM | 86323X106 | 424 | 151,611 | SH | DFND | 1,2 | 151,611 | 0 | 0 | |
SUNESIS PHARMACEUTICALS INC | COM NEW | 867328601 | 7,650 | 2,541,459 | SH | DFND | 1,2 | 2,541,459 | 0 | 0 | |
SYNERGY PHARMACEUTICALS DEL | COM NEW | 871639308 | 16,683 | 2,009,984 | SH | DFND | 1,2 | 2,009,984 | 0 | 0 | |
TENAX THERAPEUTICS INC | COM | 88032L100 | 4,091 | 1,108,593 | SH | DFND | 1,2 | 1,108,593 | 0 | 0 | |
VANDA PHARMACEUTICALS INC | COM | 921659108 | 17,939 | 1,413,599 | SH | DFND | 1,2 | 1,413,599 | 0 | 0 | |
VERICEL CORP | COM | 92346J108 | 7,447 | 2,086,028 | SH | DFND | 1,2 | 2,086,028 | 0 | 0 | |
XENOPORT INC | COM | 98411C100 | 2,973 | 485,000 | SH | DFND | 1,2 | 485,000 | 0 | 0 | |
ZOGENIX INC | COM | 98978L105 | 4,200 | 2,500,000 | SH | DFND | 1,2 | 2,500,000 | 0 | 0 | |
ALCOBRA LTD | SHS | M2239P109 | 7,777 | 1,189,086 | SH | DFND | 1,2 | 1,189,086 | 0 | 0 | |
CONNECTURE INC | COM | 20786J106 | 43,584 | 4,127,232 | SH | DFND | 1,2 | 4,127,232 | 0 | 0 |